Macrophage receptors and immune recognition

Annual Review of Immunology

Volumn 23, Issue , 2005, Pages 901-944

  Taylor, P R ^a   Martinez Pomares, L ^a   Stacey, M ^a   Lin, H H ^a   Brown, G D ^a   Gordon, S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Apoptosis; Innate immunity; Micro organisms; Pattern recognition; Phagocytosis

Indexed keywords

ANNEXIN; BETA2 GLYCOPROTEIN 1 RECEPTOR; C TYPE LECTIN DOMAIN; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; CD209 ANTIGEN; CD36 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C4 RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED MEMBRANE PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; IMMUNOGLOBULIN; INTEGRIN; LECTIN RECEPTOR; LIGAND; MACROPHAGE RECEPTOR; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; NATURAL KILLER LIKE C TYPE LECTIN RECEPTOR; PHOSPHATIDYLSERINE RECEPTOR; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TREM1 RECEPTOR; TREM2 RECEPTOR; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; BONE MARROW CELL; CELL HETEROGENEITY; CELL INTERACTION; CELL SURFACE; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOPHENOTYPING; MACROPHAGE; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPLEEN;

ANIMALS; APOPTOSIS; HUMANS; IMMUNITY, NATURAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SPLEEN;

EID: 11844254888     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.23.021704.115816     Document Type: Review

References (152)

1. Gordon S. 2003. Macrophages and the immune response. In Fundamental Immunology, ed. W Paul, pp. 481-95. Philadelphia: Lippincott Raven
2. Gordon S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927-30
3. Kaufmann SHE, Medzhitov R, Gordon S, eds. 2004. The Innate Immune Response to Infection. Washington, DC: ASM Press. 465 pp.
4. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-80
5. Inohara N. Nunez G. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3:371-82
6. Tschopp J, Martinon F, Burns K. 2003. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4:95-104
7. Janeway CA Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216
8. Brown GD, Gordon S. 2003. Fungal beta-glucans and mammalian immunity. Immunity 19:311-15
9. Krieger M. 1997. The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 8:275-80
10. Glass CK, Witztum JL. 2001. Atherosclerosis: the road ahead. Cell 104:503-16
11. Gordon S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35
12. Kraal G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31-74
13. Brown MS, Goldstein JL. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52:223-61
14. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, et al. 2001. Identification of the haemoglobin scavenger receptor. Nature 409:198-201
15. Mukhopadhyay S, Gordon S. 2004. The role of scavenger receptors in pattern recognition and innate immunity. Immunobiology. In press
16. Peiser L, De Winther MP, Makepeace K, Hollinshead M, Coull P, et al. 2002. The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect. Immun. 70:5346-54
17. Platt N, Haworth R, Darley L, Gordon S. 2002. The many roles of the class A macrophage scavenger receptor. Int. Rev. Cytol. 212:1-40
18. Kraal G, van der Laan LJ, Elomaa O, Tryggvason K. 2000. The macrophage receptor MARCO. Microbes Infect. 2:313-16
19. Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV. 2003. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198:333-40
20. Febbraio M, Hajjar DP, Silverstein RL. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108:785-91
21. Franc NC, Dimarcq JL, Lagueux M, Hoffmann J, Ezekowitz RA. 1996. Croquemort, a novel Drosophila hemocyte/ macrophage receptor that recognizes apoptotic cells. Immunity 4:431-43
22. Rainet M, Pearson A, Baksa K, Harikrishna A. 2003. Pattern recognition on receptors in Drosophila. In Innate Immunity, ed. RA Ezekowitz, JA Hoffmann, pp. 127-35. Totona, NJ: Human
23. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101:890-98
24. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. 2000. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76:227-324
25. Henson PM, Bratton DL, Fadok VA. 2001. Apoptotic cell removal. Curr. Biol. 11:R795-805
26. Savill J, Dransfield I, Gregory C, Haslett C. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965-75
27. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-16
28. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. 2000. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85-90
29. Li MO, Sarkisian MR, Mehal WZ, Rakic P, Flavell RA. 2003. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302:1560-63
30. Wang X, Wu YC, Fadok VA, Lee MC, Gengyo-Ando K, et al. 2003. Cell corpse engulfment mediated by C. elegans phosphatidylserine receptor through CED-5 and CED-12. Science 302:1563-66
31. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S. 1996. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. USA 93:12456-60
32. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392:505-9
33. Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, et al. 1998. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc. Natl. Acad. Sci. USA 95:9535-40
34. Balasubramanian K, Schroit AJ. 1998. Characterization of phosphatidylserine-dependent β2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J. Biol. Chem. 273:29272-77
35. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:781-95
36. Schagat TL, Wofford JA, Wright JR. 2001. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J. Immunol. 166:2727-33
37. Vandivier RW, Ogden CA, Fadok VA, Hoffmann PR, Brown KK, et al. 2002. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169:3978-86
38. Nakano T, Ishimoto Y, Kishino J, Umeda M, Inoue K, et al. 1997. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J. Biol. Chem. 272:29411-14
39. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, et al. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207-11
40. Fan X, Krahling S, Smith D, Williamson P, Schlegel RA. 2004. Macrophage Surface Expression of Annexins I and II in the Phagocytosis of Apoptotic Lymphocytes. Mol. Biol. Cell 15:2863-72
41. Kwakkenbos MJ, Kop EN, Stacey M, Matmati M, Gordon S, et al. 2004. The EGF-TM7 family: a postgenomic view. Immunogenetics 55:655-66
42. Schaller E, Macfarlane AJ, Rupee RA, Gordon S, McKnight AJ, Pfeffer K. 2002. Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol. Cell. Biol. 22:8035-43
43. Warschkau H, Kiderlen AF. 1999. A monoclonal antibody directed against the murine macrophage surface molecule F4/80 modulates natural immune response to Listeria monocytogenes. J. Immunol. 163:3409-16
44. Wang Y, Goldschneider I, O'Rourke J, Cone RE. 2001. Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J. Leukoc. Biol. 69:741-46
45. Lin H-H, Stacey M, Hamann J, Gordon S, McKnight AJ. 2000. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p 13.1, is closely related to CD97. Genomics 67:188-200
46. Stacey M, Chang GW, Davies JQ, Kwakkenbos MJ, Sanderson RD, et al. 2003. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulphate glycosaminoglycans. Blood 102:2916-24
47. Leemans JC, te Velde AA, Florquin S, Bennink RJ, de Bruin K, et al. 2004. The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J. Immunol. 172:1125-31
48. Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, Tak PP. 1999. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum. 42:650-58
49. Visser L, de Vos AF, Hamann J, Melief MJ, van Meurs M, et al. 2002. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. J. Neuroimmunol. 132:156-63
50. Stacey M, Lin HH, Hilyard KL, Gordon S, McKnight AJ. 2001. Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils. J. Biol. Chem. 276:18863-70
51. Hamann J, Kwakkenbos MJ, de Jong EC, Heus H, Olsen AS, van Lier RA. 2003. Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence. Eur. J. Immunol. 33:1365-71
52. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-33
53. Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ. 1992. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 175:1697-705
54. Van Amersfoort ES, Van Berkel TJ, Kuiper J. 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev. 16:379-414
55. Triantafilou M, Triantafilou K. 2002. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23:301-4
56. Ferrero E, Hsieh CL, Francke U, Goyert SM. 1990. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145:331-36
57. Juan TS, Hailman E, Kelley MJ, Busse LA, Davy E, et al. 1995. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270:5219-24
58. Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger JL, et al. 1986. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16:1583-89
59. Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, et al. 1995. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect Dis. 171:639-44
60. Lublin DM, Atkinson JP. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35-58
61. Lindahl G, Sjobring U, Johnsson E. 2000. Human complement regulators: a major target for pathogenic microorganisms. Curr. Opin. Immunol. 12:44-51
62. Ward T, Pipkin PA, Clarkson NA, Stone DM, Minor PD, Almond JW. 1994. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 13:5070-74
63. Bergelson JM, Mohanty JG, Crowell RL, St. John NF, Lublin DM, Finberg RW. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69:1903-6
64. Nowicki B, Labigne A, Moseley S, Hull R, Hull S, Moulds J. 1990. The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition. Infect. Immun. 58:279-81
65. Pham T, Kaul A, Hart A, Goluszko P, Moulds J, et al. 1995. dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor. Infect. Immun. 63:1663-68
66. Nowicki B, Selvarangan R, Nowicki S. 2001. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J. Infect Dis. 183(Suppl. 1):24-27
67. Le Bouguenec C, Lalioui L, du Merle L, Jouve M, Courcoux P, et al. 2001. Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens. J. Clin. Microbiol. 39:1738-45
68. Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V. 1987. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545-49
69. Lea S. 2002. Interactions of CD55 with non-complement ligands. Biochem. Soc. Trans. 30:1014-19
70. Hamann J, Vogel B, van Schijndel GM, van Lier RA. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184:1185-89
71. Lin HH, Stacey M, Saxby C, Knott V, Chaudhry Y, et al. 2001. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex. J. Biol. Chem. 276:24160-69
72. Lawrence DW, Bruyninckx WJ, Louis NA, Lublin DM, Stahl GL, et al. 2003. Antiadhesive role of apical decay-accelerating factor (CD55) in human neutrophil transmigration across mucosal epithelia. J. Exp. Med. 198:999-1010
73. Colonna M. 2003. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3:445-53
74. Colonna M, Facchetti F. 2003. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J. Infect. Dis. 187(Suppl. 2): S397-401
75. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, et al. 2003. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J. Immunol. 170:3812-18
76. Bouchon A, Facchetti F, Weigand MA, Colonna M. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103-7
77. Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, et al. 2003. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP 12-deficient mice. J. Clin. Invest. 111:323-32
78. Crocker PR. 2002. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr. Opin. Struct. Biol. 12:609-15
79. Crocker PR, Gordon S. 1986. Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages. J. Exp. Med. 164:1862-75
80. Jones C, Virji M, Crocker PR. 2003. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49:1213-25
81. Paul SP, Taylor LS, Stansbury EK, McVicar DW. 2000. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 96:483-90
82. Crocker PR, Varki A. 2001. Siglecs, sialic acids and innate immunity. Trends Immunol. 22:337-42
83. Brinkman-Vander Linden ECM, Angata T, Reynolds SA, Powell LD, Hedrick SM, Varki A. 2003. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol. Cell. Biol. 23:4199-206
84. Colonna M, Nakajima H, Cella M. 2000. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin. Immunol. 12:121-27
85. Ho LH, Uehara T, Chen CC, Kubagawa H, Cooper MD. 1999. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl. Acad. Sci. USA 96:15086-90
86. -/- mice. Nat. Immunol. 3:542-48
87. -/- mice. Nat. Immunol. 5:623-29
88. Barclay AN, Wright GJ, Brooke G, Brown MH. 2002. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23:285-90
89. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, et al. 2000. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290:1768-71
90. Kharitonenkov A, Chen ZJ, Sures I, Wang HY, Schilling J, Ullrich A. 1997. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386:181-86
91. Oldenborg PA, Gresham HD, Lindberg FP. 2001. CD47-signal regulatory protein α (SIRP α) regulates Fc γ and complement receptor-mediated phagocytosis. J. Exp. Med. 193:855-62
92. Brown EJ, Frazier WA. 2001. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11:130-35
93. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. 2000. Role of CD47 as a marker of self on red blood cells. Science 288:2051-54
94. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, et al. 2003. By binding SIRP α or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115:13-23
95. Toyama-Sorimachi N, Tsujimura Y, Maruya M, Onoda A, Kubota T, et al. 2004. Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc. Natl. Acad. Sci. USA 101:1016-21
96. Roda-Navarro P, Arce I, Renedo M, Montgomery K, Kucherlapati R, Fernandez-Ruiz E. 2000. Human KLRF1, a novel member of the killer cell lectin-like receptor gene family: molecular characterization, genomic structure, physical mapping to the NK gene complex and expression analysis. Eur. J. Immunol. 30:568-76
97. Marshall AS, Willment JA, Lin HH, Williams DL, Gordon S, Brown GD. 2004. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J. Biol. Chem. 279:14792-802
98. Colonna M, Samaridis J, Angman L. 2000. Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur. J. Immunol. 30:697-704
99. Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier LL. 1999. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. USA 96:9792-96
100. Raulet DH. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781-90
101. Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, et al. 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3:1142-49
102. Herre J, Gordon S, Brown GD. 2004. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol. Immunol. 40:869-76
103. Mantegazza AR, Barrio MM, Moutel S, Bover L, Week M, et al. 2004. CD63 Tetraspanin slows down cell migration and translocates to the endosomal/lysosomal/MIICs route after extracellular stimuli in human immature dendritic cells. Blood 104:1183-90
104. Willment JA, Lin HH, Reid DM, Taylor PR, Williams DL, et al. 2003. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J. Immunol. 171:4569-73
105. Steele C, Marrero L, Swain S, Harmsen AG, Zheng M, et al. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J. Exp. Med. 198:1677-88
106. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:1107-17
107. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197:1119-24
108. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, et al. 2004. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104:4038-45
109. Reid DM, Montoya M, Taylor PR, Borrow P, Gordon S, et al. 2004. Expression of the beta-glucan receptor, Dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. J. Leukoc. Biol. 76:86-94
110. Chen M, Masaki T, Sawamura T. 2002. LOX-I, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol. Ther. 95:89-100
111. Xie Q, Matsunaga S, Niimi S, Ogawa S, Tokuyasu K, et al. 2004. Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. DNA Cell Biol. 23:111-17
112. Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, et al. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353-62
113. Honjo M, Nakamura K, Yamashiro K, Kiryu J, Tanihara H, et al. 2003. Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc. Natl. Acad. Sci. USA 100:1274-79
114. Cebrian M, Yague E, Rincon M, Lopez-Botet M, de Landazuri MO, Sanchez-Madrid F. 1988. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168:1621-37
115. Marzio R, Mauel J, Betz-Corradin S. 1999. CD69 and regulation of the immune function. Immunopharmacol. Immunotoxicol. 21:565-82
116. Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, et al. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178:537-47
117. Pavlicek J, Sopko B, Ettrich R, Kopecky V Jr, Baumruk V, et al. 2003. Molecular characterization of binding of calcium and carbohydrates by an early activation antigen of lymphocytes CD69. Biochemistry 42:9295-306
118. Marzio R, Jirillo E, Ransijn A, Mauel J, Corradin SB. 1997. Expression and function of the early activation antigen CD69 in murine macrophages. J. Leukoc. Biol. 62:349-55
119. Pisegna S, Zingoni A, Pirozzi G, Cinque B, Cifone MG, et al. 2002. Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells. J. Immunol. 169:68-74
120. Lauzurica P, Sancho D, Torres M, Albella B, Marazuela M, et al. 2000. Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood 95:2312-20
121. Esplugues E, Sancho D, Vega-Ramos J, Martinez C, Syrbe U, et al. 2003. Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 197:1093-106
122. Sancho D, Gomez M, Viedma F, Esplugues E, Gordon-Alonso M, et al. 2003. CD69 downregulates autoimmune reactivity through active transforming growth factor-β production in collagen-induced arthritis. J. Clin. Invest. 112:872-82
123. Plougastel B, Dubbelde C, Yokoyama WM. 2001. Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics 53:209-14
124. Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. 2004. Missing self-recognition of Oci1/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 101:3527-32
125. Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM. 2003. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4:801-7
126. Zhou H, Kartsogiannis V, Quinn JM, Ly C, Gange C, Elliott J, et al. 2002. Osteoclast inhibitory lectin, a family of new osteoclast inhibitors. J. Biol. Chem. 277:48808-15
127. Gange CT, Quinn JM, Zhou H, Kartsogiannis V, Gillespie MT, Ng KW. 2004. Characterization of sugar binding by osteoclast inhibitory lectin. J. Biol. Chem. 279:29043-49
128. Kanazawa N, Tashiro K, Inaba K, Miyachi Y. 2003. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor γ chain. J. Biol. Chem. 278:32645-52
129. Bates EE, Fournier N, Garcia E, Valladeau J, Durand I, et al. 1999. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 163:1973-83
130. Balch SG, McKnight AJ, Seldin MF, Gordon S. 1998. Cloning of a novel C-type lectin expressed by murine macrophages. J. Biol. Chem. 273:18656-64
131. Mizuochi S, Akimoto Y, Imai Y, Hirano H, Irimura T. 1997. Unique tissue distribution of a mouse macrophage C-type lectin. Glycobiology 7:137-46
132. Tsuiji M, Fujimori M, Ohashi Y, Higashi N, Onami TM, et al. 2002. Molecular cloning and characterization of a novel mouse macrophage C-type lectin, mMGL2, which has a distinct carbohydrate specificity from mMGL1. J. Biol. Chem. 277:28892-901
133. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, et al. 1999. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J. Immunol. 163:5039-48
134. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-97
135. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, et al. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-85
136. Geijtenbeek TB, Groot PC, Nolte MA, van Vliet SJ, Gangaram-Panday ST, et al. 2002. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100:2908-16
137. Kang YS, Yamazaki S, Iyoda T, Pack M, Bruening SA, et al. 2003. SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. Int. Immunol. 15:177-86
138. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, et al. 2000. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 1:353-57
139. Park CG, Takahara K, Umemoto E, Yashima Y, Matsubara K, et al. 2001. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int. Immunol. 13:1283-90
140. Kang YS, Kim JY, Bruening SA, Pack M, Charalambous A, et al. 2004. The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc. Natl. Acad. Sci. USA 101:215-20
141. Fernandes MJ, Finnegan AA, Siracusa LD, Brenner C, Iscove NN, Calabretta B. 1999. Characterization of a novel receptor that maps near the natural killer gene complex: demonstration of carbohydrate binding and expression in hematopoietic cells. Cancer Res. 59:2709-17
142. Ariizumi K, Shen GL, Shikano S. Ritter R 3rd, Zukas P, et al. 2000. Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms. J. Biol. Chem. 275:11957-63
143. Aragane Y, Maeda A, Schwarz A, Tezuka T, Ariizumi K, Schwarz T. 2003. Involvement of dectin-2 in ultraviolet radiation-induced tolerance. J. Immunol. 171:3801-7
144. Pontow SE, Kery V, Stahl PD. 1992. Mannose receptor. Int. Rev. Cytol. 137B:221-44
145. East L, Isacke CM. 2002. The mannose receptor family. Biochim. Biophys. Acta 1572:364-86
146. Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, et al. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898-901
147. Taylor ME, Drickamer K. 1993. Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. J. Biol. Chem. 268:399-404
148. Martinez-Pomares L, Linehan SA, Taylor PR, Gordon S. 2001. Binding properties of the mannose receptor. Immunobiology 204:527-35
149. Roseman DS, Baenziger JU. 2000. Molecular basis of lutropin recognition by the mannose/GalNAc-4-SO4 receptor. Proc. Natl. Acad. Sci. USA 97:9949-54
150. Sheikh H, Yarwood H, Ashworth A, Isacke CM. 2000. Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor. J. Cell Sci. 113:1021-32
151. Engelholm LH, Nielsen BS, Dano K, Behrendt N. 2001. The urokinase receptor associated protein (uPARAP/endo180): a novel internalization receptor connected to the plasminogen activation system. Trends Cardiovasc. Med. 11:7-13
152. East L, McCarthy A, Wienke D, Sturge J, Ashworth A, Isacke CM. 2003. A targeted deletion in the endocytic receptor gene Endo180 results in a defect in collagen uptake. EMBO Rep. 4:710-16